Skip to main content
SpringerLink
Log in

Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

In the past, virtually all of the physiologic actions of angiotensin II (ANG II) were thought to be mediated by the type-1 ANG II receptor. However, there is now a compelling body of evidence suggesting that the type-2 (AT2) receptor is an important regulator of renal function and blood pressure (BP). The AT2 receptor stimulates a bradykinin (BK)-nitric oxide (NO)-cyclic GMP vasodilator cascade in blood vessels and in the kidney. Recent studies have shown that absence of the AT2 receptor lends to pressor and natriuretic hypersensitivity to ANG II. Furthermore, there is now excellent evidence that the AT2 receptor mediates pressure natriuresis. The AT2 receptor also stimulates the conversion of prostaglandin E2 (PGE2) to PGF2. In addition, it is now apparent that the therapeutic reduction in BP with AT1 receptor blockade (eg, losartan, valsartan, candesartan) is mediated by ANG II stimulation of the AT2 receptor, leading to increased levels of BK, NO, and cGMP. Current evidence predicts that AT2 receptor agonists would be beneficial in the treatment of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Matsukawa T, Ichikawa I: Biological functions of angiotensin and its receptors. Am Rev Physiol 1997, 59:395–412.

    Article  Google Scholar 

  2. Ardaillou R: Angiotensin II receptors. J Am Soc Nephrol 1999, 10:S30-S39.

    PubMed  CAS  Google Scholar 

  3. Horiuchi M, Akishita M, Dzau VJ: Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999, 33:613–621.

    PubMed  CAS  Google Scholar 

  4. Ozono R, Wang Z-Q, Moore AG, et al.: Expression of the subtype-2 angiotensin II (AT2) receptor protein in rat kidney. Hypertension 1997, 30:1238–1246.

    PubMed  CAS  Google Scholar 

  5. Wang Z-Q, Moore AF, Ozono R, et al.: Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension 1998, 32:78–83.

    PubMed  CAS  Google Scholar 

  6. Park MN, Li XF, Cowley AW Jr: Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol 1999, 277:F437-F446.

    PubMed  Google Scholar 

  7. Nora EH, Munzenmaier DH, Hansen-Smith FM, et al.: Localization of the ANG II type-2 receptor in the micro-circulation of skeletal muscle. Am J Physiol 1998, 275:H1395-H1403.

    PubMed  CAS  Google Scholar 

  8. Siragy HM, Carey RM: The subtype 2 (AT 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997, 100:264–269.

    PubMed  CAS  Google Scholar 

  9. Gohlke P, Pees C, Unger T: AT 2 receptor stimulation increases aortic cyclic GMP in SHRSP by kinin-dependent mechanisms. Hypertension 1998, 31:349–355.

    PubMed  CAS  Google Scholar 

  10. Siragy HM, Carey RM: Protective role of the angiotensin AT 2 receptor in a renal wrap hypertension model. Hypertension 1999, 33:1237–1242. This paper demonstrates for the first time that the increase in renal bradykinin with AT2 receptor stimulation is protective on blood pressure. The paper also shows for the first time that the hypotensive action of AT1 receptor blockade is mediated, at least in part, via the AT2 receptor and that pressure-natriuresis is mediated, at least in part, by the AT2 receptor.

    PubMed  CAS  Google Scholar 

  11. Siragy HM, Inagami T, Ichiki T, Carey RM: Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT 2) angiotensin receptor. Proc Natl Acad Sci U S A 1999, 96:6505–6510. This paper demonstrates pressor and natriuretic hypersensitivity to angiotensin II in the absence of the AT1 receptor. It also demonstrates that pressure-natriuresis is mediated by the AT2 receptor.

    Article  Google Scholar 

  12. Siragy HM, Carey RM: The subtype 2 angiotensin receptor regulates renal prostaglandin F2I formation. Am J Physiol 1997, 273:R1103-R1107.

    PubMed  CAS  Google Scholar 

  13. Siragy HM, Senbonmatsu T, Ichiki T, et al.: Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest 1999, 104:181–188. This paper definitively shows that the AT2 receptor mediates conversion of prostaglandin E2 (PGE2) to prostaglandin F2a (PGF2a). It also shows that increased vasodilator prostanoids maintain baseline blood pressure in the normal range in the absence of the AT2 receptor.

    PubMed  CAS  Google Scholar 

  14. Carey RM, Wang Z-Q, Siragy HM: Novel actions of angiotensin II via its renal type-2 (AT 2) receptor. Curr Hypertens Rep 1999, 1:151–157.

    PubMed  CAS  Google Scholar 

  15. Arendshorst WJ, Brannstrom K, Ruan X: Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999, 10:5149–5161.

    Google Scholar 

  16. Haithcock D, Jiao H, Cui X-L, et al.: Renal proximal tubular AT2 receptor: signalling and transport. J Am Soc Nephrol 1999, 10:S69-S74.

    PubMed  CAS  Google Scholar 

  17. Arima S, Endo Y, Yaoita H, et al.: Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of the angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997, 100:2816–2823.

    PubMed  CAS  Google Scholar 

  18. Endo Y, Arima S, Yaoita H, et al.: Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res 1998, 35:421–427.

    Article  PubMed  CAS  Google Scholar 

  19. Cao Z, Denn R, Wu L, et al.: Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 1999, 34:408–414.

    PubMed  CAS  Google Scholar 

  20. Matroughui K, Loufrani L, Heymes C, et al.: Activation of AT 2 receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999, 34:659–665.

    Google Scholar 

  21. Matsubara H, Sugaya T, Murasawa S, et al.: Tissue-specific expression of human angiotensin II AT1 and AT 2 receptors and cellular localization of subtype mRNAs in human renal cortex using in situ hybridization. Nephron 1998, 80:25–34.

    Article  PubMed  CAS  Google Scholar 

  22. Liu KL, Lo M, Grouzmann E, et al.: The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys. Br J Pharmacol 1999, 126:826–832.

    Article  PubMed  CAS  Google Scholar 

  23. Gross V, Schunck WH, Honeck H, et al.: Pressure-natriuresis in mice lacking the AT 2 receptor. Kidney Int 2000, 57:191–202. This paper definitively demonstrates that the AT2 receptor stimulates pressure-natriuresis. This is a major observation because pressurenatriuresis is inhibited in virtually all forms of hypertension.

    Article  PubMed  CAS  Google Scholar 

  24. Tanaka M, Tsuchida S, Imai T, et al.: Vascular response to angiotensin II is exaggerated through an upregulation of AT 1 receptor in AT 2 knockout mice. Biochem Biophys Res Comm 1999, 258:194–198.

    Article  PubMed  CAS  Google Scholar 

  25. Inagami T, Eguchi S, Numaguchi K, et al.: Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol 1999, 10:S57-S61.

    PubMed  CAS  Google Scholar 

  26. Tsutumi Y, Matsubara H, Masaki H, et al.: Vascular smooth muscle-targeted over-expression of angiotensin II type 2 receptor causes endothlium-dependent depressor and vasodilative effects via activation of the vascular kinin system. J Clin Invest 1999, 104:855–864. This is an outstanding paper confirming the vasodilator function of AT2 receptor stimulation that is mediated by bradykinin, nitric oxide, and guanosine cyclic 3′5′ monophosphate (cyclic GMP). Animals over-expressing the AT2 receptor in vascular smooth muscle were normotensive, but had marked attenuation of pressor responses to angiotensin II. The paper is the first to show AT2 receptor activation of kininogenase via cellular acidification.

    Article  Google Scholar 

  27. Searles CD, Harrison DG: The interaction of nitric oxide, bradykinin and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J Clin Invest 1999, 104:1013–1014.

    PubMed  CAS  Google Scholar 

  28. Barber MN, Sampey DB, Widdop RE: AT 2 receptor stimulation enhances antihypertensive effect of AT 1 receptor antagonist in hypertensive rats. Hypertension 1999, 34:1112–1116. This paper demonstrates that AT2 receptor stimulation with CGP42112 enhances the antihypertensive effect of AT1 receptor blockades in hypertensive rats. The results compliment earlier work showing that the effects of AT1 receptor blockades are mediated by the AT2 receptor and suggest that AT2 receptor agonist therapy would be beneficial in combination with AT1 receptor antagonist administration in hypertension.

    PubMed  CAS  Google Scholar 

  29. Siragy HM, deGasparo M, Carey RM: AT 2 receptor induction of bradykinin and nitric oxide mediates valsartan-induced hypotension in conscious rats. Hypertension, in press. This paper confirms that the AT2 receptor mediates the reduction in blood pressure due to AT1 receptor antagonism. The paper also indicates that the AT2 receptor pathway is bradykinin, nitric oxide, and guanosine cyclic 3′5′ monophosphate (cyclic GMP).

Download references

Author information

Authors and Affiliations

  1. From the Department of Medicine, University of Virginia School of Medicine, 22908, Charlottesville, VA, USA

    Robert M. Carey MD, Zhi-Qin Wang MD & Helmy M. Siragy MD

Authors
  1. Robert M. Carey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-Qin Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helmy M. Siragy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carey, R.M., Wang, ZQ. & Siragy, H.M. Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation. Current Science Inc 2, 198–201 (2000). https://doi.org/10.1007/s11906-000-0082-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-000-0082-3

Keywords

Search

Navigation